Does Rosuvastatin Prevent Heart Attacks? A Critical Review of the JUPITER Trial
Dr. Kumar’s Take:
The JUPITER trial found that rosuvastatin significantly reduced heart attacks and strokes in individuals with elevated C-reactive protein (CRP - a marker of inflammation) but normal LDL cholesterol. However, the absolute risk reductions were modest, raising questions about the superiority of statins over lifestyle changes. Additionally, industry funding, conflicts of interest, and the early trial termination suggest a need for caution when interpreting results. One intriguing aspect is whether statins’ anti-inflammatory effects, rather than LDL lowering, contributed to the observed benefits.